Senzime wins US deal for 23 TetraGraph systems

Press release: Uppsala March 3, 2022. Senzime announces today that the company has won an order from a large American university hospital regarding 23 TetraGraph systems and with associated disposable sensors.

All operating rooms at the university hospital are equipped with TetraGraph systems. At the same time, the surgical protocol is standardized for patients who receive muscle-blocking drugs with a requirement that these will be monitored.

There are approximately 6,000 hospitals and over 50,000 operating rooms in the United States, the world's largest market for medical equipment. Senzime is selling, through a combination of its own sales force and distributors. In the United States alone, more than 20 million patients receive muscle-blocking drugs annually as part of anesthesia. These patients need to be closely monitored with the type of technology that Senzime develops and markets to ensure the correct dosage and to determine when it is safe to wake the patient after surgery.

“We have now won the procurement in another important hospital in the United States, and it is our assessment that their decision to standardize the use of objective monitoring to protect their patients from potential complications is something we will see more of.”, says Pia Renaudin, CEO of Senzime

Contact us

Want to know more?

How can Senzime’s innovative patient monitoring solutions help to eliminate in-hospital complications?
Contact us today.